Sagarsoft’s™ Partnership Approach, Data Analysis in Pharmacoeconomics & Pfizer’s Market Access Strategy

Web Portfolio

project info

Domain: Web Application
Online Links:
tpaw.coreaccessgroup.com
zapp.coreaccessgroup.com
Client Profile: www.coreaccessgroup.com
Technology: ASP.Net, AJAX, MS SQL Server, JQuery, Javascript, Obout Control

How Sagarsoft’s™ Partnership Approach & Data Analysis in Pharmacoeconomics Created Substantial Leverage for Pfizer’s™ Market Access Strategy by Core Access™

Data Analysis, a core competency at Sagarsoft™, continually derives novel strategies from its diverse domain experiences. Our partnership with Core Access™ motivated the team to develop fresh insights when dealing with data in the Pharmacoeconomics and Insurance Risk spheres.

We helped roll out application portfolios for Pfizer™ that maximized their marketing efficiency in two entirely different market segments. Core Access Group™ helps Pfizer™ plan their market access strategies for a number of drug classes including Zyvox™ and Toviaz™.

We supported Core Access™ deliver exceptional context sensitive graphical applications, implementing inter related criteria. Our solution sets help analyze competitive drug utilization in hospitals as well as payer market dynamics, using multiple dimensions across geographies.

Toviaz™ Market Analysis – TPAW™

ZAPP™ helps view comparative analysis of drug utilization across hospitals for MRSA – a condition caused by drug resistant bacteria. Information can be filtered by a number of hospital specific attributes for displaying graphical statistics data.
Further utilization data is available based on payer characteristics and can be displayed as trends, heat maps, ranking reports and bar charts.

Key Insights

Our partnership approach facilitates smooth project flow through the use of agreed upon checkpoints, complete transparency and joint decision making with the client. During the short tenure of this project, we realized how such a methodology, when preserved in its entirety could successfully cater to changing requirements from the client even in the absence of essential documentation.
A closely knit team responded very well to frequent changes in massive data sets and could seamlessly incorporate analysis criteria modifications and new parameter cascades with minimal time and effort.
Testing and Quality Assurance procedures at pre-determined stages minimized chances of inconsistencies, from development through deployment. Our approach helped preserve application integrity and eliminated chances of costly bug fixes or code rework.

About Zyvox™ & Toviaz™

Pfizer™ targets drug resistant bacterial and complex skin infections through its Zyvox™ oral and IV preparation. Toviaz™ is an oral pill for an overactive bladder. More information is available at www.toviaz.com and www.pfizerpro.com/hcp/zyvox